SelectScience
Join Free
Accelerating Science
NewsClinical Diagnostics

LGC and Aptahem combine on first large-scale production campaign of Apta-1

LGC Diagnostics and Genomics - Lucigen Reagent Components

The collaboration is the first larger scale production run of Apta-1 as a non-GMP material, intended for use in GLP toxicology studies

24 Aug 2020
Diane Li
Assistant Editor

Product news

Aptahem AB, a leading developer of aptamer-based drugs, has announced that the company is now starting large-scale manufacturing after LGC completed the Process Development (PD) work enabling larger Pilot scale production campaigns of Apta -1.

This campaign is now the first larger scale production run of Apta-1 as a non-GMP material, intended for use in GLP toxicology studies. The preceding PD work also enables LGC to manufacture Apta-1 under GMP for use in the first human clinical trial. However, continuous PD work will focus on optimisation of manufacturing cost, and to further improve process, such as yield and purity. The progress made in process optimisation is also a result of long and careful analytical development work by LGC's AxoLabs. This analytical development has been key to assess the set-up parameters necessary for the scale-up and in process control.

“We are excited to announce that the collaboration with LGC as our long-term partner to scale up production of Apta-1 for our development program, which has now reached a first milestone in production settings,” says Mikael Lindstam, CEO of Aptahem, who continues, “We will not rest at this as together with LGC we will continue to optimise the process for forthcoming manufacturing but we have now reached a good starting point.”

Thomas Rupp, Subject Matter Expert on Nucleic Acid manufacturing, CMC consultant to Aptahem, says, “Because of its highly structured aptamer nature, the manufacturing and analytical characterisation of Apta-1 proved unexpectedly challenging. LGC has utilised their outstanding experience in the field of Nucleic Acids to deliver tremendous analytical and process development work facilitating the manufacturing of the Aptahem lead compound, whilst maintaining scaleability and cost of the process.”

David Griffiths, Ph.D., Managing Director, Nucleic Acid Therapeutics Solutions, LGC, says, “Aptahem is a dynamic company and leader in an exciting and innovative field. The LGC team is delighted by the collaboration with Aptahem to develop the Apta-1 programme. Our core purpose is science for a safer world and we have applied all our specialist knowledge and capabilities to help Aptahem progress with their mission.”

Want more of the latest science news straight to your inbox? Become a SelectScience member for free today>>

Links

LGC Diagnostics and Genomics - Lucigen Reagent ComponentsCompany website

Tags

Data AnalysisData analysis hardware and software is available to make data processing straight-forward yet powerful. Data software can be used for math and stats, technical graphing and image analysis. In addition, software is available for specific data analysis of electrophoresis, densitometry, ELISA and DNA sequencing.Biopharmaceutical AdvancesBiopharmaceutical advances follow the development of pharmaceuticals derived from biotechnology, also known as biotechnology medicines. Biopharmaceuticals may be produced from cell lines, plants, or microbial cells. Important considerations of biopharmaceutical use include application, cost, production process and purification.Clinical ChemistryBiochemistry (or clinical chemistry) involves the analysis of bodily fluids using chemical tests. Techniques used include HPLC, chromatography, spectroscopy, mass spectrometry, immunochemical, electrophoresis, turbidometric / spectrophotometric assay, MRI and ISE analysis. Tests are often carried out on plasma or serum but urine (urinalysis) and fecal specimens are also processed.Clinical GeneticsMolecular Genetics covers the analysis of hereditary genetic disease and chromosomal abnormalities. Genetics can be analysed using DNA, RNA, and protein microarrays, PCR, RT PCR and DNA sequencing. Genetic equipment includes genetic workstations, thermal cyclers, cooling blocks and electrophoresis products. Diagnostic kits are used for DNA / RNA extraction and purification.Toxicology / Drugs of Abuse TestingToxicology and Drugs of Abuse Testing is the investigation into toxic and illegal substances found at the scene of a crime or from a suspect and / or victim associated with a scene of a crime. Analyzers, immunoassays and drugs of abuse test kits and presumptive test kits are an essential aspect of toxicology investigation.RegulatoryPharmaceutical regulations impact on all areas of drug development, manufacture and control and supply. Services are provided from the early stages of drug development and clinical trials through to dossier submission, approval and marketing. Regulatory also includes submission of analytical studies from the pharmaceutical product and safety. Scale-upScale-Up is generally defined as the process of transferring the results of the discovery phases of the drug discovery process, obtained on a laboratory scale, to the pilot plant and finally to production scale. Scale-Up uses reactors and pump systems as well as reagents, standards and buffers. Often Scale-Up is provided as a service by Contract Manufacturing Organizations (CMOs). Drug DiscoveryDrug discovery is the process of identifying potential new medications, involving stages such as target identification, compound screening, and preclinical development. It relies on cutting-edge technologies like high-throughput screening, artificial intelligence, and molecular modeling to accelerate the identification of drug candidates. Drug discovery plays a pivotal role in developing new therapies for diseases ranging from cancer to rare genetic disorders. Browse our peer-reviewed product directory to find the latest drug discovery technologies, compare options, check customer feedback, and get pricing directly from manufacturers.Drug DevelopmentDrug development refers to the process of bringing a new drug to market.

Related articles